Caplacizumab Human Monoclonal Antibody
Caplacizumabis a research-grade recombinant antibody targeting von Willebrand antigen II. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Von Willebrand antigen II, von Willebrand factor, F8VWF, vWF, VWF
UniProt
P04275
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
20 mM citric acid, 6.2% sucrose,0.01% Tween80
Isotype
VH-VH
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TJP2 Antibody - C-terminal region : HRP (ARP42942_P050-HRP)
Ptk2 (NM_007982) Mouse Tagged ORF Clone Lentiviral Particle